1,2,3,4,6-Penta- O -galloyl-β- d -glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 12, 2011, Pages 6765-6775

  Huang, Hsiu Chen ^a   Lin, Chih Li ^b   Lin, Jen Kun ^c  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

anticancer; curcumin; lycopene; pentagalloylglucose; quercetin; Skp2

Indexed keywords

ANTICANCER; CURCUMIN; LYCOPENES; PENTAGALLOYLGLUCOSE; QUERCETIN; SKP2;

CELL GROWTH; CYTOLOGY; DEGRADATION; DISEASES; FATTY ACIDS; GLUCOSE; GROWTH KINETICS; PHENOLS; PROTEINS;

CELLS;

BETA PENTA O GALLOYL GLUCOSE; BETA-PENTA-O-GALLOYL-GLUCOSE; CAROTENOID; CURCUMIN; LYCOPENE; QUERCETIN; S PHASE KINASE ASSOCIATED PROTEIN; TANNIN;

ARTICLE; BREAST TUMOR; CELL CYCLE; DOWN REGULATION; DRUG EFFECT; FEMALE; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CAROTENOIDS; CELL CYCLE; CELL LINE, TUMOR; CURCUMIN; DOWN-REGULATION; FEMALE; HUMANS; HYDROLYZABLE TANNINS; QUERCETIN; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 79959262105     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf201096v     Document Type: Article

References (41)

1. Morabito, A.; Magnani, E.; Gion, M.; Sarmiento, R.; Capaccetti, B.; Longo, R.; Gattuso, D.; Gasparini, G. Prognostic and predictive indicators in operable breast cancer Clin. Breast Cancer 2003, 3 (6) 381-90 (Pubitemid 36395547)
2. Gstaiger, M.; Jordan, R.; Lim, M.; Catzavelos, C.; Mestan, J.; Slingerland, J.; Krek, W. Skp2 is oncogenic and overexpressed in human cancers Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (9) 5043-8 (Pubitemid 32397079)
3. Kudo, Y.; Kitajima, S.; Ogawa, I.; Miyauchi, M.; Takata, T. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma Oral Oncol. 2005, 41 (2) 105-16 (Pubitemid 40202876)
4. Zhu, C. Q.; Blackhall, F. H.; Pintilie, M.; Iyengar, P.; Liu, N.; Ho, J.; Chomiak, T.; Lau, D.; Winton, T.; Shepherd, F. A.; Tsao, M. S. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker Clin. Cancer Res. 2004, 10 (6) 1984-91 (Pubitemid 38375557)
5. Signoretti, S.; Di Marcotullio, L.; Richardson, A.; Ramaswamy, S.; Isaac, B.; Rue, M.; Monti, F.; Loda, M.; Pagano, M. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer J. Clin. Invest. 2002, 110 (5) 633-41 (Pubitemid 34988787)
6. Sonoda, H.; Inoue, H.; Ogawa, K.; Utsunomiya, T.; Masuda, T. A.; Mori, M. Significance of skp2 expression in primary breast cancer Clin. Cancer Res. 2006, 12 (4) 1215-20 (Pubitemid 43342511)
7. Zheng, X. Y.; Ding, W.; Xie, L. P.; Chen, Z. D. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer] Aizheng 2004, 23 (2) 215-8
8. Kamata, Y.; Watanabe, J.; Nishimura, Y.; Arai, T.; Kawaguchi, M.; Hattori, M.; Obokata, A.; Kuramoto, H. High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma J. Cancer Res. Clin. Oncol. 2005, 131 (9) 591-6 (Pubitemid 41558552)
9. Farhana, L.; Dawson, M.; Rishi, A. K.; Zhang, Y.; Van Buren, E.; Trivedi, C.; Reichert, U.; Fang, G.; Kirschner, M. W.; Fontana, J. A. Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway Cancer Res. 2002, 62 (13) 3842-9 (Pubitemid 34728870)
10. Wang, C. X.; Koay, D. C.; Edwards, A.; Lu, Z.; Mor, G.; Ocal, I. T.; Digiovanna, M. P. In vitro and in vivo effects of combination of Trastuzumab (Herceptin) and Tamoxifen in breast cancer Breast Cancer Res. Treat. 2005, 92 (3) 251-63 (Pubitemid 41279635)
11. Ropero, S.; Menendez, J. A.; Vazquez-Martin, A.; Montero, S.; Cortes-Funes, H.; Colomer, R. Trastuzumab plus tamoxifen: anti-proliferative and molecular interactions in breast carcinoma Breast Cancer Res. Treat. 2004, 86 (2) 125-37 (Pubitemid 38988016)
12. Davidovich, S.; Ben-Izhak, O.; Shapira, M.; Futerman, B.; Hershko, D. D. Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer Breast Cancer Res. 2008, 10 (4) R63
13. La Vecchia, C.; Decarli, A.; Negri, E.; Parazzini, F. Epidemiological aspects of diet and cancer: a summary review of case-control studies from northern Italy Oncology 1988, 45 (5) 364-70
14. Tsugane, S. [Dietary factor and cancer risk - evidence from epidemiological studies] Gan to Kagaku Ryoho 2004, 31 (6) 847-52
15. Park, O. J.; Surh, Y. J. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies Toxicol. Lett. 2004, 150 (1) 43-56 (Pubitemid 38447236)
16. Cline, J. M.; Hughes, C. L., Jr. Phytochemicals for the prevention of breast and endometrial cancer Cancer Treat. Res. 1998, 94, 107-34
17. Kaur, M.; Agarwal, R. Transcription factors: molecular targets for prostate cancer intervention by phytochemicals Curr. Cancer Drug Targets 2007, 7 (4) 355-67 (Pubitemid 46849240)
18. Johnson, I. T. Phytochemicals and cancer Proc. Nutr. Soc. 2007, 66 (2) 207-15 (Pubitemid 46684974)
19. Huang, H. C.; Way, T. D.; Lin, C. L.; Lin, J. K. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein Endocrinology 2008, 149 (12) 5972-83
20. Zhao, W. H.; Gao, C. C.; Ma, X. F.; Bai, X. Y.; Zhang, Y. X. The isolation of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose from Acer truncatum Bunge by high-speed counter-current chromatography J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007, 850 (1-2) 523-7
21. Martinez-Dominguez, E.; de la Puerta, R.; Ruiz-Gutierrez, V. Protective effects upon experimental inflammation models of a polyphenol-supplemented virgin olive oil diet Inflammation Res. 2001, 50 (2) 102-6 (Pubitemid 32210151)
22. Rudrappa, T.; Bais, H. P. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models J. Agric. Food Chem. 2008, 56 (6) 1955-62 (Pubitemid 351497852)
23. Khachik, F.; Carvalho, L.; Bernstein, P. S.; Muir, G. J.; Zhao, D. Y.; Katz, N. B. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health Exp. Biol. Med. (Maywood) 2002, 227 (10) 845-51 (Pubitemid 35340337)
24. Saijo, R.; Nonaka, G.; Nishioka, I. Tannins and related compounds. LXXXIV. Isolation and characterization of five new hydrolyzable tannins from the bark of Mallotus japonicus Chem. Pharm. Bull. (Tokyo) 1989, 37 (8) 2063-70
25. Clarke, M. J. WITHDRAWN: Tamoxifen for early breast cancer Cochrane Database Syst. Rev. 2008, 4 CD000486
26. Sit, K. H.; Bay, B. H.; Wong, K. P. Effect of genistein, a tyrosine-specific protein kinase inhibitor, on cell rounding by pH upshifting In Vitro Cell. Dev. Biol.; Anim. 1993, 29A (5) 395-402 (Pubitemid 23187760)
27. Katagiri, Y.; Hozumi, Y.; Kondo, S. Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo J. Dermatol. Sci. 2006, 42 (3) 215-24
28. Sun, L.; Cai, L.; Yu, Y.; Meng, Q.; Cheng, X.; Zhao, Y.; Sui, G.; Zhang, F. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin Acta Biochim. Biophys. Sin. (Shanghai) 2007, 39 (12) 999-1007 (Pubitemid 350274290)
29. Yang, C. S.; Wang, Z. Y. Tea and cancer J. Natl. Cancer Inst. 1993, 85 (13) 1038-49 (Pubitemid 23199184)
30. Hirayama, T. A large scale cohort study on cancer risks by diet - with special reference to the risk reducing effects of green-yellow vegetable consumption Princess Takamatsu Symp. 1985, 16, 41-53
31. Aggarwal, B. B.; Banerjee, S.; Bharadwaj, U.; Sung, B.; Shishodia, S.; Sethi, G. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines Biochem. Pharmacol. 2007, 73 (7) 1024-32 (Pubitemid 46283583)
32. Shao, Z. M.; Shen, Z. Z.; Liu, C. H.; Sartippour, M. R.; Go, V. L.; Heber, D.; Nguyen, M. Curcumin exerts multiple suppressive effects on human breast carcinoma cells Int. J. Cancer 2002, 98 (2) 234-40 (Pubitemid 34150808)
33. Nahum, A.; Hirsch, K.; Danilenko, M.; Watts, C. K.; Prall, O. W.; Levy, J.; Sharoni, Y. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes Oncogene 2001, 20 (26) 3428-36 (Pubitemid 32588991)
34. Chen, W. J.; Chang, C. Y.; Lin, J. K. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip) Biochem. Pharmacol. 2003, 65 (11) 1777-85
35. Hua, K. T.; Way, T. D.; Lin, J. K. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells Mol. Carcinog. 2006, 45 (8) 551-60
36. De, S.; Chakraborty, R. N.; Ghosh, S.; Sengupta, A.; Das, S. Comparative evaluation of cancer chemopreventive efficacy of alpha-tocopherol and quercetin in a murine model J. Exp. Clin. Cancer Res. 2004, 23 (2) 251-8 (Pubitemid 38943556)
37. Surh, Y. J.; Chun, K. S. Cancer chemopreventive effects of curcumin Adv. Exp. Med. Biol. 2007, 595, 149-72
38. Chisholm, K.; Bray, B. J.; Rosengren, R. J. Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells Anticancer Drugs 2004, 15 (9) 889-97 (Pubitemid 39482930)
39. Bar-On, O.; Shapira, M.; Hershko, D. D. Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells Anticancer Drugs 2007, 18 (10) 1113-21 (Pubitemid 47480736)
40. Ferlini, C.; Scambia, G.; Distefano, M.; Filippini, P.; Isola, G.; Riva, A.; Bombardelli, E.; Fattorossi, A.; Benedetti Panici, P.; Mancuso, S. Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis Br. J. Cancer 1997, 75 (6) 884-91 (Pubitemid 27110706)
41. McDougal, A.; Wormke, M.; Calvin, J.; Safe, S. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator Cancer Res. 2001, 61 (10) 3902-7 (Pubitemid 32720948)